ProfileGDS4718 / 222745_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 86% 83% 80% 84% 88% 77% 82% 84% 82% 84% 86% 84% 85% 81% 78% 82% 84% 78% 81% 89% 83% 83% 84% 81% 84% 77% 83% 74% 84% 81% 83% 82% 81% 86% 83% 77% 85% 82% 83% 80% 85% 89% 80% 80% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.5682686
GSM549102patient 115, normal, homogenized [OPG study]8.0932883
GSM549104patient 119, normal, homogenized [OPG study]7.956180
GSM549108patient 138, normal, homogenized [OPG study]8.1847784
GSM549119patient 077, normal, homogenized [OPG study]8.8278688
GSM549133patient 032, cancer, homogenized [OPG study]7.641577
GSM549139patient 042, cancer, homogenized [OPG study]8.0955182
GSM549099patient 107, normal, homogenized [OPG study]8.31584
GSM549109patient 139, normal, homogenized [OPG study]7.9768182
GSM549110patient 046, normal, homogenized [OPG study]8.2886684
GSM549114patient 063, normal, homogenized [OPG study]8.7436186
GSM549122patient 082, normal, homogenized [OPG study]8.2850884
GSM549134patient 033, cancer, homogenized [OPG study]8.445185
GSM549136patient 036, cancer, homogenized [OPG study]8.1159881
GSM549140patient 044, cancer, homogenized [OPG study]7.7618378
GSM549111patient 047, normal, homogenized [OPG study]8.1254282
GSM549113patient 057, normal, homogenized [OPG study]8.4171784
GSM549132patient 031, cancer, homogenized [OPG study]7.706678
GSM549137patient 038, cancer, homogenized [OPG study]8.0481881
GSM549142patient 047, cancer, homogenized [OPG study]8.6053789
GSM549100patient 110, normal, homogenized [OPG study]8.1919383
GSM549107patient 135, normal, homogenized [OPG study]8.2574783
GSM549115patient 068, normal, homogenized [OPG study]8.4928884
GSM549116patient 072, normal, homogenized [OPG study]7.986381
GSM549120patient 078, normal, homogenized [OPG study]8.339784
GSM549131patient 030, cancer, homogenized [OPG study]7.6387177
GSM549118patient 074, normal, homogenized [OPG study]8.269983
GSM549129patient 027, cancer, homogenized [OPG study]7.2773974
GSM549123patient 088, normal, homogenized [OPG study]8.329184
GSM549124patient 006, cancer, homogenized [OPG study]7.9295581
GSM549126patient 015, cancer, homogenized [OPG study]8.1369783
GSM549128patient 025, cancer, homogenized [OPG study]8.1915382
GSM549103patient 117, normal, homogenized [OPG study]7.8745481
GSM549117patient 073, normal, homogenized [OPG study]8.6699986
GSM549138patient 041, cancer, homogenized [OPG study]8.2450683
GSM549141patient 045, cancer, homogenized [OPG study]7.6803877
GSM549130patient 028, cancer, homogenized [OPG study]8.3389685
GSM549101patient 111, normal, homogenized [OPG study]7.9943782
GSM549105patient 128, normal, homogenized [OPG study]8.2054983
GSM549106patient 134, normal, homogenized [OPG study]8.0032480
GSM549112patient 048, normal, homogenized [OPG study]8.4290585
GSM549125patient 011, cancer, homogenized [OPG study]8.9139389
GSM549127patient 024, cancer, homogenized [OPG study]7.9541880
GSM549135patient 035, cancer, homogenized [OPG study]7.9395580